| Stage | ALCO | % of rev | CTVA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9M | 100.00% | $6.4B | 100.00% | CTVA ×705.64 |
| Gross profit | $4M | 44.76% | $3.7B | 57.39% | CTVA +12.6pp |
| Operating income | $2M | 20.86% | $1.8B | 28.01% | CTVA +7.2pp |
| Pre-tax income | $1M | 16.31% | $1.6B | 25.47% | CTVA +9.2pp |
| Net income | $2M | 17.33% | $1.2B | 18.26% | CTVA +0.9pp |
| Stage | ALCO | CTVA | Gap · A − B |
|---|---|---|---|
| Revenue | $9M100.00% | $6.4B100.00% | CTVA ×705.64 |
| Gross profit | 44.76%$4M | 57.39%$3.7B | CTVA +12.6pp |
| Operating income | 20.86%$2M | 28.01%$1.8B | CTVA +7.2pp |
| Pre-tax income | 16.31%$1M | 25.47%$1.6B | CTVA +9.2pp |
| Net income |
| 17.33%$2M |
| 18.26%$1.2B |
| CTVA +0.9pp |
No shared counterparties.